Alcon, Inc.
Alcon's Second Quarter Sales Rise 17.9 Percent; Net Earnings Increase 26.3 Percent
Published in Drug Law Weekly, August 12th, 2008
Alcon, Inc. (NYSE:ACL) reported global sales of $1,735.2 million for the second quarter of 2008, an increase of 17.9 percent compared to the second quarter of 2007, or 11.2 percent excluding the impact of foreign exchange fluctuations. Net earnings for the second quarter of 2008 increased 26.3 percent to $566.4 million, or $1.88 per share on a diluted basis, compared to $448.4 million, or $1.48 per share for the second quarter of 2007.
"The results for the second quarter demonstrate the benefits of our global operations that experienced strong growth in our core product lines and solid sales performance around the world," said Cary Rayment, Alcon's chairman, president...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-08-12)
More Articles from Drug Law Weekly
- AIDS Healthcare Foundation
Congress Approves Global AIDS Bill Which Will Save Five to Seven Million Lives - Alzheimer Disease
Allon Therapeutics presents AL-108 human efficacy data at worlds leading Alzheimers disease conference - American Lung Association
American Lung Association Congratulates the U.S. House of Representatives for Passage of Historic Tobacco Legislation - American Public Health Association
APHA Urges House to Protect Health of Americans by Passing Tobacco Legislation - American Public Health Association
PHA Commends House Passage of Tobacco Legislation - Bioscience
Immuneregen Biosciences Advances Toward Ind Filing; Homspera Clears Initial Toxicity Hurdle - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
